In December 2013, UNICEF published its first comprehensive evaluation assessing how well its global and country strategies and programmes have worked to protect children in emergencies.
The ‘Evaluation of UNICEF Programmes to Protect Children in Emergencies’ was undertaken to identify key suc...cesses and gaps in child protection programming over the period 2009-2012 and to draw out lessons learned ahead of the roll-out of the new Strategic Plan, 2014-2017. The evaluation investigates achievements and gaps against the Core Commitments for Children in Humanitarian Action (CCCs), UNICEF’s Child Protection Strategy and the previous Strategic Plan, 2006-2013. It assesses the extent to which interventions in longer term
child protection systems-strengthening and preparedness have led to a more effective response in crises.
more
This interagency report provides recommendations for assuring quality of medicines during key activities of country-level procurement agencies, namely prequalification of pharmaceutical products and manufacturers; purchase of pharmaceutical products; storage of pharmaceutical products; and distribut...ion of pharmaceutical products.
more
BMJ 2020;368:m800 doi: 10.1136/bmj.m800 (Published 5 March 2020)
The international community sits at the tipping pointof a post-‐antibiotic era, where common bacterial infections are no longer treatable with the antibiotic armamentarium that exists. In South Africa, t...he identification of the first case of pan-‐resistant Klebsiella pneumoniae(Brink et al, J Clin Microbiol. 2013;51(1):369-‐72) marks a watershed moment and highlights ourtip of the antibiotic resistance ‘iceberg’ in this country. Multi-‐drug resistant (MDR)-‐bacterial infections, predominantly in Gram-‐negative bacteria such as Klebsiella pneumoniae, Escherichia coli, Pseudomonas aeruginosaand Acinetobacter baumanniiare now commonplace in South African hospitals. Whilst a number of expensive new antibiotics for Gram-‐positive bacterial infections have been manufactured recently (some of which are licenced for usein South Africa), no new antibiotics active against Gram-‐negative infections are expected in the next 10-‐15years. Hence what we have now, needs conserving
more
Prêt au retour: dossier de formation à la préparation des enseignants vous guidera à travers une réflexion sur l’impact du COVID-19 sur les pratiques pédagogiques quotidiennes et vous fournira des conseils et des suggestions que vous pourrez appliquer en classe. Les informations fournies ici... ne sont qu’une première introduction ; nous espérons que vous les trouverez instructives et utiles, que vous explorerez les sujets plus en profondeur, que vous en discuterez avec vos collègues et que vous utiliserez les ressources disponibles qui vous permettront de changer durablement la vie de vos élèves.
more
This article looks at the Baseline Standards developed by the International Society for Paediatric
Oncology (SIOP) for paediatric oncology nursing care in low- and middle-income countries. The
Baseline Standards lay the foundation for effective care and address barriers such as inadequate
staffin...g levels, lack of support, limited access to nurse education and unsafe nursing environments.
more
The aims of this publication is to highlight the lack of diversity in medical literature and education
European Journal of Biomedical and Pharmaceutical Sciences, vol.3 (2016) 1, 192-206
This review shows that if all sub areas of pharmaceutical waste management can efficiently work back to back environmental pollution and dangers to human health can reduce significantly.
World Journal of Pharmaceutical and Medical Research vol. 5 (2019) 3, 129-132
Senegal is home to nearly 2 million girls and women who have experienced FGM. Overall, 25 per cent of girls and women have undergone the practice, varying from over 90 per cent in Kédougou to just under 1 per cent in Diourbel
Female Genital Mutilation in Mali: Insights from a statistical analysis Mali is home to nearly 8 million girls and women who have experienced FGM. Overall, 89 per cent of girls and women aged 15 to 49 years have undergone the practice, ranging from 96 per cent in Sikasso region to 1 per cent or less... in Gao and Kidal
more
On 13 and 14 May 2022, North Korea reported 1,74,400 and 2,60,000 new COVID-19 cases and 21 and 15 deaths, respectively. It is thus hard to believe that the country was officially free from the pandemic until 11 May the same year. On 12 May, Pyongyang admitted to around 5,24,440 total COVID-19 cases... in the period late-April to 13 May 2022. Reportedly, 2,43,630 are now fully cured and 2,80,810 are being treated
more
Дитячий фонд ООН (ЮНІСЕФ) доставив на Полтавщину критично важливу гуманітарну допомогу на 800 000 доларів. 340 тон гуманітарного вантажу мають покрити потреби більш як ...півмільйона мешканців Полтавcької області.
Велика частина вантажу - товари медичного призначення: акушерські та гігієнічні набори, бинти, глюкоза, інфузійні та аспіраційні помпи, портативні реєстратори електрокардіографії, портативні апарати ультразвукової
діагностики, пульсоксиметри.
more
Chikungunya fever (CHIKF) is an emerging infectious disease caused by an alphavirus transmitted by Aedes spp. mosquitoes. Because mosquito control programs are not highly efficient for outbreak containment, vaccines are essential to reduce the burden of disease. Although no licensed vaccine against ...CHIKF is yet available, many highly promising candidates are undergoing preclinical studies, and a few of them have been tested in human trials of phase 1 or 2. Here, we review recent findings regarding the need for a CHIKF vaccine and provide an update on vaccines nearing or having entered clinical trials. We also address needs to tackle bottlenecks to vaccine development—including scientific and financial barriers—and to accelerate the development of vaccines; several actions should be taken:
(i) design efficacy trials to be conducted during the course of outbreaks;
(ii) evaluate the opportunity for adopting the “animal rule”for demonstration of efficacy for regulatory purposes;
(iii) strengthen the collective commitment of nations, international organizations, potential donors and industry;
(iv) stimulate public and/or private partnerships to invest in vaccine development and licensure; and
(v) identify potential markets for an effective and safe CHIKF vaccine.
more